Puma Biotechnology Inc. (PBYI)
NASDAQ · Healthcare
Puma Biotechnology Inc. Net Income 2017–2025
Puma Biotechnology Inc. annual/quarterly net income history and growth rate from 2017 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Puma Biotechnology Inc. net income for the quarter ending March 31, 2026 was -3.8 M, a 226.19% decrease year-over-year.
- Puma Biotechnology Inc. net income for the twelve months ending March 31, 2026 was 13.9 M, a 16.99% decrease year-over-year.
- Puma Biotechnology Inc. annual net income for 2025 was 31.1 M, a 2.75% increase from 2024.
- Puma Biotechnology Inc. annual net income for 2024 was 30.3 M, a 40.23% increase from 2023.
- Puma Biotechnology Inc. annual net income for 2023 was 21.6 M, a 1079450.00% increase from 2022.
- Puma Biotechnology Inc. annual net income for 2022 was 2000.
Net Income
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Puma Biotechnology Inc. Net Income — FAQ
Puma Biotechnology Inc. (PBYI) net income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Puma Biotechnology Inc.'s net income?
Puma Biotechnology Inc. (PBYI) reported net income of $31M for fiscal 2025.
Where can I see PBYI's net income history?
The chart and table above show Puma Biotechnology Inc.'s net income by year and by quarter, including the growth rate.